DEA Locks Down Seven Sneaky Fentanyl Cousins in Schedule I
Published Date: 9/18/2025
Rule
Summary
The DEA is officially putting seven specific fentanyl-related substances into Schedule I, meaning they’re now treated as very dangerous drugs with strict rules. This affects anyone who makes, sells, studies, or even holds these substances, who must follow tough laws and face serious penalties if they don’t. These changes take effect right away, aiming to keep communities safer and stop illegal use.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Seven Fentanyl-Related Drugs Now Schedule I
The DEA officially placed seven specified fentanyl-related substances (including their isomers, esters, ethers, and salts) into Schedule I under the Controlled Substances Act. That means anyone who manufactures, distributes, imports, exports, possesses, or handles these substances is now subject to the full regulatory controls and criminal, civil, and administrative sanctions that apply to Schedule I drugs.
Research and Instruction Now Covered by Schedule I Rules
The rule explicitly subjects research, instructional activities, and chemical analysis involving these seven fentanyl-related substances to Schedule I controls. If you study or teach about these substances or run chemical analyses, you must now follow Schedule I requirements for handling and possession.
Regulation Aims to Improve Community Safety
The DEA states the action is intended to keep communities safer and stop illegal use by treating these seven fentanyl-related substances as Schedule I drugs. The change is effective immediately to strengthen enforcement and controls.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
Previous / Next Documents
Previous: 2025-18094, Safety Zone; San Pedro Bay, Long Beach, CA
The Coast Guard is setting up a temporary safety zone around Port of Long Beach Berth G232 and first-responder boats to keep everyone safe from floating shipping containers. No boats or people can enter these zones unless the Captain of the Port says it’s okay. This helps protect workers, vessels, and the environment during cleanup efforts.
Next: 2025-18149, Standard Instrument Approach Procedures, and Takeoff Minimums and Obstacle Departure Procedures; Miscellaneous Amendments
This update changes some airport approach and takeoff rules to keep flights safe and smooth. It affects pilots flying in certain airports by updating how they land and take off, based on new tech and obstacles. These changes start soon and help everyone fly smarter without extra costs.